ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2012
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Discrete choice experiments in health economics: a review of the literature.PharmacoEconomics · 2014Pooled it
- Risk as an attribute in discrete choice experiments: a systematic review of the literature.The patient · 2014Pooled it
- A Pilot Study to Evaluate the Use of Automated Nicotine Metabolite Ratio Reporting Within Primary Care as an Implementation Strategy to Increase the Use of Tobacco Treatments.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- Article
- Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.Addiction neuroscience · 2023Article
- Physicians' preferences and willingness to pay for artificial intelligence-based assistance tools: a discrete choice experiment among german radiologists.BMC health services research · 2022Article
- Methods Used in Smoking Cessation and Reduction Attempts: Findings from Help-Seeking Smokers.Journal of smoking cessation · 2021Article
- Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2020Article
- The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.Cancer prevention research (Philadelphia, Pa.) · 2020Review
- E-cigarette Product Preferences among Adult Smokers: A Discrete Choice Experiment.Tobacco regulatory science · 2020Article
- Product attributes important to US adult consumers' use of electronic nicotine delivery systems: a discrete choice experiment.BMJ open · 2019Article
- To "vape" or smoke? Experimental evidence on adult smokers.Economic inquiry · 2019Article
- The impact of flavour, device type and warning messages on youth preferences for electronic nicotine delivery systems: evidence from an online discrete choice experiment.Tobacco control · 2018Article
- Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review.PharmacoEconomics - open · 2018Review
- Eliciting preferences for waterpipe tobacco smoking using a discrete choice experiment: implications for product regulation.BMJ open · 2015Article
- Assessing preferences for a university-based smoking cessation program in Lebanon: a discrete choice experiment.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015Article
- Smaller Cigarette Pack as a Commitment to Smoke Less? Insights from Behavioral Economics.PloS one · 2015Article
- Willingness to pay for quality of life technologies to enhance independent functioning among baby boomers and the elderly adults.The Gerontologist · 2014Article
- A Cross-sectional Examination of What Smokers Perceive to be Important and Their Willingness to Pay for Tobacco Cessation Medications.Journal of public health management and practice : JPHMPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of smoking cessation medications can considerably enhance the long-term abstinence rate at a reasonable cost, but only a small proportion of quitters seek medical assistance. The objective of this study was to evaluate the factors that influence the decision to use such treatments and the willingness-to-pay of smokers for improved cessation drugs.
methodA discrete choice experiment was conducted amongst smokers in the French-speaking part of Switzerland. Choice sets consisted of two hypothetical medications described via five attributes (price, efficacy, possibility of minor side effects, attenuation of weight gain and availability) and an opt-out option. Various discrete choice models were estimated to analyse both the factors that influence treatment choice and those that influence the overall propensity to use a smoking cessation medication.
resultsOur results indicate that smokers are willing to pay for higher efficacy, less-frequent side effects and prevention of weight gain. Whether the drug is available over-the-counter or on medical prescription is of secondary importance. In addition, we show that there are several individual-specific factors influencing the decision to use such medications, including education level. Results also indicate substantial preference heterogeneity.
conclusionThis study shows that there is a potential demand for improved cessation medications. Broader usage could be reached through lower out-of-pocket price and greater efficacy. Secondary aspects such as side effects and weight gain should also be taken into consideration.
Indexed as
Identifiers
21706307What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.